TMIC-36. LOCAL TISSUE BIOMARKERS OF RESPONSE TO THERAPY FOR GLIOBLASTOMA

Glioblastoma (GBM) is a common deadly malignant brain cancer of the central nervous system (CNS), with a median survival of 12–15 months. Scientific advancements are lacking in developing effective therapies for both primary GBM, as well as secondary GBMs, that typically originate as malignant trans...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Rajani, Karishma, Olson, Ian, Jacobs, Joshua, Macura, Slobodan, Sarkaria, Jann, Burns, Terry
Format: Artigo
Language:Inglês
Published: Oxford University Press 2018
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216454/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.1095
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items